Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

Medicine & Health

Cancer Immunotherapy

Curated Collections

Cancer immunotherapies harness the body’s immune system to fight cancer. In general, immunotherapies either train the immune system to identify and attack cancer cells (e.g. adoptive cell therapy and cancer vaccines), or thwart the ability of cancer cells to evade the body's natural antitumor immune response (e.g. checkpoint inhibitors). In this Editor’s Picks, Associate Editor Jenna Wilson highlights recent research on potential immunotherapies and the cancer immune environment, including topics featured at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting.

Image Credit: 10.1371/journal.pone.0146885.g001

Perspectives on Immunotherapy
Checkpoint Inhibitors
Adoptive Cell Transfer
Cancer Vaccines
Combination Therapies
Tumor Immune Microenvironment
Prognostic Biomarkers
PLOS Welcomes Cancer Immunotherapy Research

Which journal is right for your work?

Editor's Picks Collections

Browse recent research highlights as selected by PLOS ONE Editors

View Collections
Back to top